Nektar Therapeutics (NKTR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 589.04M | 266.27M | 281.36M | 186.57M | 229.91M | 261.29M | 286.48M | 295.19M | 319.84M | 330.7M | 399.02M | 441.06M |
| Cash & Short-Term Investments | 568.6M | 245.75M | 270.21M | 175.9M | 218.63M | 255.23M | 244.5M | 271.24M | 289.24M | 303.62M | 372.66M | 409.43M |
| Cash Only | 131.87M | 15.12M | 41.03M | 42.99M | 38.89M | 44.25M | 30.11M | 13.92M | 48.64M | 35.28M | 64.92M | 50.73M |
| Short-Term Investments | 436.74M | 230.64M | 229.18M | 132.91M | 179.74M | 210.97M | 214.39M | 257.31M | 240.6M | 268.34M | 307.74M | 358.7M |
| Accounts Receivable | 3.6M | 1.78M | 1.29M | 1.35M | 1.71M | 1.61M | 2.12M | 2.9M | 5.43M | 2.25M | 3.43M | 3.87M |
| Days Sales Outstanding | 22.29 | 6.47 | 10.3 | 12.48 | 14.3 | 5.88 | 9.58 | 16.14 | 16.16 | 10.94 | 13.9 | 15.23 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.46M | 16.24M | 16.1M | 15.13M | 20.69M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | 143.43 | 172.42 | 197.26 | 132.55 | 266.23 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 33.05M | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 174.23M | 14.14M | 19.99M | 20.97M | 26.33M | 42.56M | 21.48M | 48.15M | 76.18M | 67.33M | 43.22M | 53.22M |
| Property, Plant & Equipment | 4.72M | 5M | 10M | 10.57M | 11.16M | 11.82M | 12.43M | 24.43M | 34.74M | 36.86M | 38.7M | 51.57M |
| Fixed Asset Turnover | 2.23x | 2.91x | 1.15x | 1.03x | 0.91x | 2.41x | 1.31x | 0.79x | 0.60x | 0.63x | 0.53x | 0.34x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 164.73M | 3.49M | 4.84M | 5.37M | 9.78M | 26.09M | 4.54M | 19.41M | 36.78M | 25.82M | 0 | 0 |
| Other Non-Current Assets | 4.78M | 5.65M | 5.16M | 5.02M | 5.39M | 4.65M | 4.52M | 4.31M | 4.66M | 4.64M | 4.52M | 1.65M |
| Total Assets | 763.27M | 280.41M | 301.35M | 207.53M | 256.24M | 303.85M | 307.97M | 343.33M | 396.01M | 398.03M | 442.24M | 494.28M |
| Asset Turnover | 0.02x | 0.07x | 0.05x | 0.05x | 0.04x | 0.10x | 0.07x | 0.06x | 0.05x | 0.06x | 0.05x | 0.04x |
| Asset Growth % | 197.87% | -7.72% | -2.15% | -39.55% | -35.29% | -23.66% | -30.36% | -30.54% | -29.5% | -43.99% | -43.38% | -42.66% |
| Total Current Liabilities | 57.71M | 53.54M | 66.34M | 71.39M | 70.93M | 61.4M | 67.58M | 57.33M | 52.41M | 51.27M | 52.11M | 50.69M |
| Accounts Payable | 10.03M | 10.77M | 15.56M | 14.28M | 17.83M | 11.56M | 8.58M | 6.47M | 8.76M | 9.85M | 3.29M | 2.62M |
| Days Payables Outstanding | 6.2K | - | 7K | - | - | 116.12 | 156.12 | 71.16 | 99.19 | 82.97 | 21.86 | 41.08 |
| Short-Term Debt | 22.53M | 20.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 20.14M | 22.27M | 8.61M | 6.55M | 5.03M | 5.55M | 12.13M | 20.8M | 7.38M | 5.55M | 11.48M | 10.67M |
| Current Ratio | 10.21x | 4.97x | 4.24x | 2.61x | 3.24x | 4.26x | 4.24x | 5.15x | 6.10x | 6.45x | 7.66x | 8.70x |
| Quick Ratio | 10.21x | 4.97x | 4.24x | 2.61x | 3.24x | 4.26x | 4.24x | 4.90x | 5.79x | 6.14x | 7.37x | 8.29x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | 88.41 | 89.38 | 125.23 | 124.59 | 240.38 |
| Total Non-Current Liabilities | 129.35M | 137.04M | 149.92M | 160.35M | 171.57M | 181.71M | 191.5M | 206.32M | 216.9M | 215.78M | 230.76M | 246.63M |
| Long-Term Debt | 60.27M | 63.16M | 0 | 0 | 0 | 0 | 0 | 107.51M | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 60.63M | 65.26M | 69.73M | 74.14M | 78.5M | 82.7M | 86.76M | 90.76M | 94.71M | 98.52M | 102.19M | 105.82M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 8.45M | 8.63M | 80.19M | 86.21M | 93.08M | 99.02M | 104.74M | 8.05M | 122.19M | 117.26M | 128.57M | 140.81M |
| Total Liabilities | 187.06M | 190.57M | 216.26M | 231.75M | 242.5M | 243.11M | 259.08M | 263.65M | 269.31M | 267.05M | 282.88M | 297.32M |
| Total Debt | 143.43M | 148.91M | 91.92M | 96.16M | 100.34M | 102.56M | 108.26M | 219.61M | 114.08M | 117.78M | 121.29M | 124.75M |
| Net Debt | 11.56M | 133.79M | 50.88M | 53.17M | 61.44M | 58.31M | 78.15M | 205.69M | 65.44M | 82.5M | 56.37M | 74.02M |
| Debt / Equity | 0.25x | 1.66x | 1.08x | - | 7.30x | 1.69x | 2.21x | 2.76x | 0.90x | 0.90x | 0.76x | 0.63x |
| Debt / EBITDA | - | - | - | - | - | 6.99x | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | 3.97x | - | - | - | - | - | - |
| Interest Coverage | -4.82x | -1.95x | -4.88x | -6.30x | -8.32x | 1.69x | -5.15x | -7.16x | -5.66x | -5.13x | -6.77x | -7.32x |
| Total Equity | 576.22M | 89.83M | 85.09M | -24.21M | 13.74M | 60.74M | 48.88M | 79.69M | 126.7M | 130.99M | 159.37M | 196.96M |
| Equity Growth % | 4094.32% | 47.9% | 74.06% | -130.38% | -89.16% | -53.63% | -69.33% | -59.54% | -47.4% | -64.27% | -61.34% | -57.06% |
| Book Value per Share | 23.29 | 4.43 | 6.04 | -1.72 | 0.98 | 4.27 | 3.50 | 5.72 | 9.76 | 10.28 | 12.55 | 15.58 |
| Total Shareholders' Equity | 576.22M | 89.83M | 85.09M | -24.21M | 13.74M | 60.74M | 48.88M | 79.69M | 126.7M | 130.99M | 159.37M | 196.96M |
| Common Stock | 3K | 2K | 2K | 1K | 19K | 19K | 19K | 19K | 19K | 19K | 19K | 19K |
| Retained Earnings | -3.81B | -3.76B | -3.72B | -3.69B | -3.65B | -3.6B | -3.6B | -3.57B | -3.51B | -3.48B | -3.44B | -3.39B |
| Treasury Stock | 0 | 0 | 0 | -3M | -3M | -3M | -3M | -3M | -3M | 0 | 0 | 0 |
| Accumulated OCI | -1.03M | 17K | 56K | -14K | 39K | 61K | 355K | -494K | -403K | 80K | -6.35M | -6.45M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |